SurgLine International Inc. Stock Analysis SGLN
SurgLine International, Inc. operates as a development stage holding company, which engages in surgical and solar photovoltaic cell technology products, through its subsidiaries. The company is headquartered in West Palm Beach, Florida and currently employs 0 full-time employees. The company went IPO on 2001-09-27. The Company’s core business is to source and sell surgical implants, medical, dental and surgical disposable products used by physicians and dentists. SurgLine International, Inc. and its wholly owned subsidiary SurgLine Inc is developing a physician office allergy testing program using Sublingual Immunotherapy also known as SLIT. SurgLine offers products via its website www.surglinesupplies.com. Some Its products include Spine Hardware such as Cervical PEEK Interbody Fusion Device (IBFD) , Anterior, Posterior and Transformal Lumbar Interbody Fusion (TLIF) System; Surgical Sets: includes tray, instruments, screws, implants; Surgical Instruments include Scissors, forceps, basket punches, saw blades, reamers, pulse lavage; Drill System and Power Tools include Cordless & pneumatic drills, chucks, sleeves, saws, hoes, charges and batteries.
Read More SurgLine International Inc (SGLN) Chart
Financial Metrics & Statements of SurgLine International Inc (SGLN)
FAQ's for SurgLine International Inc (SGLN)
- According to Musaffa’s Shariah screening methodology, SurgLine International Inc (SGLN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.